A Comparative Clinical trial to study the effect of Takradhara and Shiro-abhyang with Yashtimadhuadya Tail in the management of Generalized Anxiety Disorder

A Comparative Clinical study of Takradhara and Shiro-abhyang with Yashtimadhuadya Tail in the management of Chittodvega (Generalized Anxiety Disorder)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036359

Enrollment

Registered

2021-09-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

Intervention1: takradhara in chittodvega: 1 takradhara in chittodvega for 7 days 2 shiro-abhyang with yashtimadhuadhya tail for 7 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1 DSM-IV 2 patients with anxiety from last 6 months

Exclusion criteria

Exclusion criteria: 1 patients above 70 and below 20 years of age 2 patients with any severe systemic illness

Design outcomes

Secondary

Measure	Time frame
Assessment of change in the clinical parametersTimepoint: Total study period 12 months and Treatment period 3 weeks	—

Primary

Measure	Time frame
Change in classical sign and symptoms of chittodvega (At the time of baseline and at the end of the treatment)Timepoint: Total study period 12 months and treatment period 3 weeks	—

Countries

India

Contacts

Public ContactDr Monika das

Shubhdeep ayurved medical college

dasmonika16@gmail.com9425320769

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026